Clinical Trial Update: A Clinical Trial of Patients With Solid Tumours Receiving Granulocyte Colony Stimulating Factor as Primary Prophylaxis for Chemotherapy-induced Neutropenia, in a Docetaxel Based Regimen [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating granulocyte colony-stimulating factor as primary prophylaxis for chemotherapy-induced neutropenia in patients with solid tumors receivi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Granulocyte Colony Stimulating Factor (granulocyte colony-stimulating factor (G-CSF))

Snippet

Sponsor: Sanofi | Conditions: Neoplasms (no Otherwise Specified) | Phase 4 | Status: COMPLETED